Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA
NCT06525948 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2024-07-29
Summary
Investigating the efficacy and safety of rhTPO in combination with cyclosporine versus cyclosporine alone for the treatment of TD-NSAA
Conditions
- Aplastic Anemia
- Transfusion-dependent Anemia
Interventions
- DRUG
-
rhTPO
rhTPO
- DRUG
-
Cyclosporin A
cyclosporine A
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Principal Investigators
-
Bing Han, PhD · Peking Union Medical College
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-30
- Primary Completion
- 2025-06-30
- Completion
- 2025-12-30
Countries
- China
Study Locations
More Related Trials
-
A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
NCT04231292 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
NCT07075484 ·Status: COMPLETED ·Phase: PHASE1
-
Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia
NCT00954486 ·Status: WITHDRAWN ·Phase: NA
-
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
NCT03010579 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
NCT02586402 ·Status: UNKNOWN ·Phase: PHASE2
-
rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics
NCT02356419 ·Status: UNKNOWN ·Phase: PHASE1
-
Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
NCT06552429 ·Status: RECRUITING ·Phase: PHASE2
-
Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia
NCT05691257 ·Status: UNKNOWN ·Phase: PHASE4
-
Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06238544 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .
NCT05629598 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
NCT03950687 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia
NCT01464164 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
NCT05773586 ·Status: RECRUITING ·Phase: PHASE1
-
Two Different Regiments of Pegmolesatide for Anemia in Patients With Chronic Kidney Disease Not Receiving Dialysis
NCT06946394 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis
NCT00236964 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
NCT02969655 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma
NCT04910594 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease
NCT04885647 ·Status: COMPLETED ·Phase: PHASE2
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255424 ·Status: COMPLETED ·Phase: PHASE3
-
Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy
NCT02860598 ·Status: UNKNOWN
-
Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan
NCT03329196 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia
NCT02964936 ·Status: COMPLETED ·Phase: PHASE3
-
Apotransferrin in Patients With β-thalassemia
NCT03993613 ·Status: TERMINATED ·Phase: PHASE2
-
Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection
NCT03786289 ·Status: COMPLETED ·Phase: PHASE1
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255437 ·Status: COMPLETED ·Phase: PHASE3